Home › Cancer (all types) › NCT05842902
Resilience Mobile App for Teens and Young Adults With Cancer
Recruiting
Pilot Trial Testing Mobile Health Psychosocial Intervention for Adolescents and Young Adults With Cancer
Who can join
Ages 12 to 25 · All sexes
Full eligibility criteria
Inclusion Criteria: * Age 12-25 years * Diagnosis of new malignancy within 12 months of enrollment treated with chemotherapy and/or radiation therapy at Seattle Children's Hospital (SCH) * Patient able to speak/read/write English or Spanish language * Cognitively able to participate in mHealth psychosocial intervention and interactive interviews Exclusion Criteria: * Patient refusal to participate (any age), or parental refusal to participate for patients less than 18 years of age * Patients with diagnosis of malignancy \>12 months * Patients with relapsed, recurrent, or refractory disease * Patient without chemotherapy and/or radiation therapy as part of cancer treatment (e.g., surgical resection only patients are not-eligible) * Cognitively or physically unable to participate in mHealth psychosocial intervention and surveys
About the study
The goal of this pilot trial is to examine whether a mobile app version of the Promoting Resilience in Stress Management (PRISM) intervention is acceptable, easy to use, and helps improve quality of life and mental health symptoms.
What is being tested
- mPRISM (behavioral)
Sponsor: Seattle Children's Hospital · Participants: 80 · Started: Sep 12, 2023
Contact the study team
- Nancy Lau, PhD · Phone: 206-884-0569
Official record on ClinicalTrials.gov — NCT05842902
Locations in the U.S.
| Washington | Seattle Children's Hospital, Seattle |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.